Business & Regulation

Alcami experts discuss what’s needed to accelerate drug development.

EU-based associations voice concerns over joint clinical assessments and the lack of advice meetings.

From wearable health tech to telehealth, here’s how digital transformation could impact the pharma industry and patient access.

Why a forward-thinking approach is crucial for patient safety and industry success

A Pistoia Alliance survey looks at stakeholder concerns in AI regulations, and calls for more harmonization and collaboration.

How will digitalization and automation redefine pharma manufacturing in the next decade?

Now, it’s time to start the integration process. Here are some top tips and points to consider.

Colleen Dixon and Mary Glotzbach discuss key areas for improvement, including automation, eco-friendly practices, and patient-centric delivery methods

The 2024 Access to Medicine Index has a new leader, but analysts are concerned about stakeholder commitment.

Controversial and divisive, but Kennedy’s expertise is intended for one thing: change.